INR 883.4
(2.51%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 537.66 Million INR | 28.66% |
2022 | 417.88 Million INR | 44.36% |
2021 | 289.46 Million INR | 2.74% |
2020 | 281.75 Million INR | 11.19% |
2019 | 253.4 Million INR | -22.06% |
2018 | 325.12 Million INR | 33.89% |
2017 | 242.82 Million INR | 1.56% |
2016 | 239.1 Million INR | 46.4% |
2015 | 163.32 Million INR | -7.32% |
2014 | 176.22 Million INR | 40.67% |
2013 | 125.27 Million INR | 14.14% |
2012 | 109.76 Million INR | 7.89% |
2011 | 101.73 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q2 | 357.04 Million INR | 0.0% |
2023 FY | 537.66 Million INR | 28.66% |
2023 Q4 | 537.66 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2022 Q4 | 417.88 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 417.88 Million INR | 44.36% |
2022 Q2 | 302.68 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 FY | 289.46 Million INR | 2.74% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 255 Million INR | 0.0% |
2021 Q4 | 289.46 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 281.75 Million INR | 11.19% |
2020 Q4 | 281.75 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 353.7 Million INR | 0.0% |
2019 Q4 | 253.4 Million INR | 0.0% |
2019 FY | 253.4 Million INR | -22.06% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 289.22 Million INR | 0.0% |
2018 FY | 325.12 Million INR | 33.89% |
2018 Q4 | 325.12 Million INR | 0.0% |
2018 Q2 | 312.42 Million INR | 0.0% |
2017 Q2 | 201.3 Million INR | 0.0% |
2017 Q4 | 242.82 Million INR | 0.0% |
2017 FY | 242.82 Million INR | 1.56% |
2016 Q1 | 186.84 Million INR | 0.0% |
2016 FY | 239.1 Million INR | 46.4% |
2016 Q4 | 239.1 Million INR | 25.61% |
2016 Q3 | 190.35 Million INR | 0.0% |
2015 FY | 163.32 Million INR | -7.32% |
2014 FY | 176.22 Million INR | 40.67% |
2013 FY | 125.27 Million INR | 14.14% |
2012 FY | 109.76 Million INR | 7.89% |
2011 FY | 101.73 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Biocon Limited | 49.43 Billion INR | 98.912% |
Blue Jet Healthcare Limited | 1.29 Billion INR | 58.589% |
Concord Biotech Limited | 2.07 Billion INR | 74.145% |
Dishman Carbogen Amcis Limited | 8.82 Billion INR | 93.91% |
Jubilant Ingrevia Limited | 9.41 Billion INR | 94.288% |
Lyka Labs Limited | 95.71 Million INR | -461.714% |
Panacea Biotec Limited | 1.77 Billion INR | 69.784% |
Piramal Pharma Limited | 21.75 Billion INR | 97.529% |
SMS Lifesciences India Limited | 812.1 Million INR | 33.794% |
Supriya Lifescience Limited | 852.49 Million INR | 36.931% |
Syngene International Limited | 2.38 Billion INR | 77.457% |
TAKE Solutions Limited | 7.96 Million INR | -6654.535% |